Pharmaceutical Germany-based biotech ATAI Life Sciences, a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, and UniQuest, Australia’s leading university technology transfer company commercializing the research of The University of Queensland (UQ), today announced the launch of InnarisBio Inc, to develop a novel sol-gel intranasal drug delivery technology to improve treatments for mental health disorders. 28 July 2021